查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲立體定位神經導航系統市場：分析與預測（2025-2035）
市場調查報告書
商品編碼
1781116

歐洲立體定位神經導航系統市場：分析與預測（2025-2035）

Europe Stereotactic Neuro-Navigation System Market: Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 63 Pages | 商品交期: 1-5個工作天內

價格

預計歐洲立體定位神經導航系統市場規模將從2024年的2.69億美元成長到2035年的10.142億美元，預測期內的年複合成長率為 13.14%。

歐洲立體定位神經導航產業持續保持兩位數成長，這得益於神經系統疾病盛行率的不斷上升，以及導航輔助手術相較於傳統外科手術的顯著優勢。擴增實境（AR）、機器學習和人工智慧等技術的進步拓展這些平台的應用範圍，並提高手術精度。微創手術的興起進一步推動了對高精度導航技術的需求。此外，人口老化導致的與老齡化相關的神經系統疾病發生率上升也是推動市場擴張的另一個因素。

主要市場統計資料
預測期 2025-2035
2025年評估 2.95億美元
2035年預測 10.142億美元
年複合成長率 13.14%

先進導航系統高成本，難以與現有IT和影像系統整合，以及術中併發症的可能性，都可能成為其應用的障礙。然而，持續的技術創新、歐盟支持性法規結構（例如，簡化的MDR途徑）以及神經導航技術向脊椎和顱顏外科等相關領域的擴展，預計將推動市場保持成長動力，並在歐洲進一步擴張。

由於對微創手術和精準引導神經外科的需求不斷成長，歐洲立體定位神經導航系統市場預計將大幅成長。這些系統在深部腦部刺激、腫瘤切片檢查、功能性神經外科等領域正受到越來越多的關注，因為它們能夠提供即時3D解剖映射和手術路徑規劃。此外，該地區人口老化以及癲癇、腦腫瘤和帕金森氏症等神經系統疾病盛行率的上升，促使醫院投資先進的導航系統，以降低手術風險並改善患者預後。

技術創新也在推動市場擴張。擴增實境（AR）疊加技術、人工智慧手術計劃演算法以及與術中 MRI/CT 掃描儀的無縫整合，提高手術精度和工作流程效率。雲端基礎的個案管理和遠距協作技術也日益普及，使得多家醫療機構共用專業知識，並加快術前準備。此外，西歐優惠的償付制度和東歐不斷成長的醫療支出也推動了這些技術的採用。

然而，應用障礙依然存在。高昂的初始設置成本、軟體許可費用、與現有影像診斷設備和醫院IT系統的複雜整合，以及外科醫生需要進行高級培訓，這些都可能阻礙其廣泛應用，尤其是在中小型區域性醫院。此外，嚴格遵守歐盟醫療設備夥伴關係（MDR）會增加時間和成本負擔。展望未來，醫療設備製造商、學術機構和醫療機構之間持續的研發合作，以及系統間互通性的標準化努力，預計將進一步擴大臨床應用範圍，並推動市場穩步成長。

市場區隔:

細分1：依地區

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他

本報告調查了歐洲立體定位神經導航系統市場，並總結了主要趨勢、市場影響因素分析、法律制度、技術和專利分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局和主要企業的概況。

目錄

執行摘要

範圍和定義

第1章 市場：產業展望

  • 市場趨勢
    • 利用協同效應效應實現業務組合多元化
  • 償付情景
  • 監管狀況/合規性
    • 歐洲
  • 供應鏈分析
  • 定價分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機會

第2章 立體定位神經導航系統市場（依地區）

  • 歐洲
    • 區域概況
    • 市場成長動力
    • 市場問題
    • 英國
    • 德國
    • 法國
    • 其他

第3章 市場：競爭基準化分析與公司概況

  • 關鍵策略和發展
  • 產品基準
  • 市場佔有率
  • 公司簡介
    • Medtronic Plc
    • Brainlab AG
    • Elekta

第4章 調查方法

This report can be delivered in 2 working days.

Introduction to Europe Stereotactic Neuro-Navigation System Market

The Europe stereotactic neuro-navigation system market is projected to reach $1,014.2 million by 2035 from $269.0 million in 2024, growing at a CAGR of 13.14% during the forecast period 2025-2035. The growing prevalence of neurological illnesses and the obvious benefits of navigation-assisted operations over traditional surgery have been driving double-digit growth in the stereotactic neuro-navigation industry in Europe. Advancements like augmented reality, machine learning, and artificial intelligence are expanding the use of these platforms and improving surgical accuracy. There is now a greater need for high-precision navigation technologies due to the move towards less intrusive procedures. Another factor supporting market expansion is an ageing population, which is contributing to an increase in age-related neurological diseases.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$295.0 Million
2035 Forecast$1,014.2 Million
CAGR13.14%

The high cost of sophisticated navigation systems, the difficulty of integrating them with current IT and imaging systems, and the possibility of intraoperative problems, however, can all be barriers to adoption. Notwithstanding these obstacles, continued technological advancements, pro-EU regulatory frameworks (such as streamlined MDR pathways), and the expansion of neuro-navigation into related specialities like spinal and craniofacial surgery are expected to maintain momentum and spur additional expansion throughout Europe.

Market Introduction

The market for stereotactic neuro-navigation systems in Europe is expected to develop significantly due to the rising demand for minimally invasive interventions and precision-guided neurosurgery procedures. These systems are becoming more and more popular for deep brain stimulation, tumour biopsies, epilepsy surgeries, and functional neurosurgery because they offer real-time, three-dimensional anatomical mapping and trajectory planning. Because of the region's ageing population and increased prevalence of neurological conditions including epilepsy, brain tumours, and Parkinson's disease, hospitals are investing in cutting-edge navigation systems that lower operating risks and enhance patient outcomes.

Technological advancements are driving market expansion: augmented reality overlays, AI-powered planning algorithms, and smooth integration with intraoperative MRI/CT scanners are improving surgical precision and workflow effectiveness. Cloud-based case management and remote collaboration technologies are also becoming more popular since they facilitate the sharing of expertise across many sites and expedite preoperative preparation. Adoption is also being aided by favourable reimbursement practices in Western Europe and rising healthcare spending in Eastern Europe.

Adoption obstacles still exist, though. Uptake may be slowed, particularly in smaller community hospitals, by high acquisition and software-licensing costs, complicated integration with legacy imaging and hospital IT systems, and the requirement for intensive surgeon training. Time and expense are increased by strict adherence to the EU Medical Device Regulation. In the future, it is anticipated that continued research and development partnerships among device makers, academic institutions, and healthcare providers-as well as initiatives to standardise interoperability-will expand clinical applications and propel steady expansion throughout the European stereotactic neuro-navigation market.

Market Segmentation:

Segmentation 1: by Region

  • Europe
    • Germany
    • U.K.
    • France
    • Rest-of-Europe

Europe Stereotactic Neuro-Navigation System Market Trends, Drivers and Challenges

Market Trends

  • Rising adoption of frameless, image-guided navigation systems offering enhanced ergonomics and workflow integration
  • Integration with intraoperative MRI/CT and augmented reality for real-time anatomical visualization
  • AI-driven planning tools that automate trajectory optimization and risk assessment
  • Cloud-based platforms enabling multi-site data sharing and remote surgical planning
  • Hybrid OR deployments combining neuro-navigation with robotics for end-to-end precision

Key Drivers

  • Growing incidence of brain tumors, movement disorders, and epilepsy fueling demand for precise surgical guidance
  • Shift toward minimally invasive neurosurgical techniques to reduce patient morbidity and hospitalization
  • Increased healthcare spending and favorable reimbursement policies across Western and Eastern Europe
  • Collaboration between device manufacturers and leading academic centers accelerating clinical validation
  • Need for streamlined workflows to boost OR efficiency and reduce procedure times

Major Challenges

  • High capital and recurring software-license costs limiting uptake in smaller hospitals
  • Complex integration with legacy imaging equipment and hospital IT systems
  • Steep learning curve for surgeons and OR staff requiring dedicated training programs
  • Evolving EU MDR requirements prolonging time to market and increasing compliance costs
  • Data-security and patient-privacy concerns around cloud-based case storage and analytics

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Medtronic Plc
  • Brainlab AG
  • Elekta

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Leveraging Synergies to Diversify Business Portfolio
  • 1.2 Reimbursement Scenario
  • 1.3 Regulatory Landscape/Compliance
    • 1.3.1 Europe
      • 1.3.1.1 U.K.
  • 1.4 Supply Chain Analysis
  • 1.5 Pricing Analysis
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Rising Prevalence of Neurological Disorders
      • 1.6.1.2 Benefits Offered by Navigation-Assisted Surgeries Over Conventional Surgeries
    • 1.6.2 Market Restraints
      • 1.6.2.1 Complications Associated with the Use of Navigation Systems
      • 1.6.2.2 High Cost of Acquisition
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Integration of Artificial Intelligence (AI) and Machine Learning

2 Stereotactic Neuro-navigation System Market (By Region), $Million, 2023-2035

  • 2.1 Europe
    • 2.1.1 Regional Overview
    • 2.1.2 Driving Factors for Market Growth
    • 2.1.3 Factors Challenging the Market
    • 2.1.4 U.K.
    • 2.1.5 Germany
    • 2.1.6 France
    • 2.1.7 Rest of the Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Key Strategies and Development
  • 3.2 Product Benchmarking
  • 3.3 Market Share
  • 3.4 Company Profiles
    • 3.4.1 Medtronic Plc
      • 3.4.1.1 Overview
      • 3.4.1.2 Top Products/Product Portfolio
      • 3.4.1.3 Top Competitors
      • 3.4.1.4 Target Customers
      • 3.4.1.5 Key Personal
      • 3.4.1.6 Analyst View
    • 3.4.2 Brainlab AG
      • 3.4.2.1 Overview
      • 3.4.2.2 Top Products/Product Portfolio
      • 3.4.2.3 Top Competitors
      • 3.4.2.4 Target Customers
      • 3.4.2.5 Key Personal
      • 3.4.2.6 Analyst View
    • 3.4.3 Elekta
      • 3.4.3.1 Overview
      • 3.4.3.2 Top Products/Product Portfolio
      • 3.4.3.3 Top Competitors
      • 3.4.3.4 Target Customers
      • 3.4.3.5 Key Personal
      • 3.4.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Stereotactic Neuro-Navigation System Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Stereotactic Neuro-Navigation System Market, $Million, 2024 and 2035
  • Figure 3: EU Classification
  • Figure 4: NHS Classification
  • Figure 5: Supply Chain and Risks within the Supply Chain
  • Figure 6: Prevalence of Parkinson's Disease (by Region), 2016-2021
  • Figure 7: Increasing Incidence of CNS Brain Tumor Cases (by Region), 2022, 2025, 2035, and 2045
  • Figure 8: Increasing Aging Population Globally, Million, 2020-2023
  • Figure 9: Europe Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 10: Europe Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 11: Europe Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 12: Incidences of Neurological Disorders in U.K., Million, 2018-2021
  • Figure 13: U.K. Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 14: Incidences of Neurological Disorders in Germany, Million, 2018-2021
  • Figure 15: Germany Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 16: Incidences of Neurological Disorders in France, Million, 2018-2021
  • Figure 17: France Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 18: Incidences of Neurological Disorders in Rest-of-Europe, Million, 2018-2021
  • Figure 19: Rest-of-Europe Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 20: Strategic Initiatives, January 2017-May 2025
  • Figure 21: Data Triangulation
  • Figure 22: Top-Down and Bottom-Up Approach
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Some of the Key Developments
  • Table 4: CPT Coding
  • Table 5: Inpatient Reimbursement
  • Table 6: Price of Stereotactic Neuro-Navigation System
  • Table 7: Drivers, Restraints, and Opportunities: Current and Future Impact Assessment
  • Table 8: Comparison between Various Navigation-Assisted Surgeries Over Conventional Surgeries
  • Table 9: Sources of Error in Navigated Surgery
  • Table 10: Cost of Acquisition of Key Neuro-Navigation Systems
  • Table 11: Stereotactic Neuro-Navigation System Market (by Region), $Million, 2023-2035
  • Table 12: U.K. Incidences of Neurological Disorders, By Disease Type, 2018-2021
  • Table 13: Germany Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 14: France Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 15: Rest-of-Europe Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 16: Some of the Strategies and Development, January 2017-May 2025
  • Table 17: Europe Stereotactic Neuro-Navigation System Market, Product Benchmarking (by Product)
  • Table 18: Market Share Analysis, 2024